Hadassah

Israeli Start-Up Partners with Health Industry Leaders to Enhance Assessment of Head Trauma

Friday, Dec 8 2017

Two of the Hadassah Medical Organization’s physicians-- Prof. Moshe Gomori, head of Magnetic Resonance Imaging (MRI) and the Neuroradiology Unit, and Prof. Yacov (Jacob) Sosna, Director of the Department of Radiology and Medical Imaging--are on the Scientific Advisory Board of an Israeli startup that has developed an artificial intelligence-based software to help clinicians more accurately assess head trauma or stroke.

The company, called MedyMatch, has now entered its third partnership with health care industry leaders to integrate its products with their imaging technology.

The MedyMatch software provides support to imaging experts working in hospital emergency rooms and other acute care settings. For example, in its latest partnership with GE Healthcare, MedyMatch will integrate its intracranial hemorrhage (“brain bleed”) detection platform into GE’s CT (computed tomography) imaging. The goal is to enhance the assessment capability of clinicians with patients suspected of having intracranial hemorrhage--providing a second diagnostic eye in the reading of images.

The other two partnerships are with IBM Watson Health and Samsung NeuroLogica.

“Non-contrast CT remains the primary imaging modality for the initial evaluation of patients with suspected stroke or traumatic brain injury,” says Gene Saragnese, Chairman and Chief Executive Officer of MedyMatch. He explains: “MedyMatch is bringing to market a new category of medical solutions that leverages deep learning, machine vision, and the full richness of 3-D imaging and other relevant patient data.”

MedyMatch points out that “there are currently no automated tools in emergency or radiology departments that are in use to assist physicians in detecting intracranial hemorrhage.” MedyMatch’s mission is to “harness clinical understanding in conjunction with machine vision and deep learning to deliver real-time, artificial intelligence-based support to physicians in the assessment of patients in the Emergency Room without disrupting the clinical workflow.”

Learn more about the Hadassah Medical Organization.

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Wednesday, Jun 12 2019

Multinational Study Reveals Reduction in Kidney Disease Progression with Diabetes Drug

In a large multinational study that revealed the effectiveness of a medicine called dapagliflozin in reducing cardiovascular death from heart failure among high-risk diabetic patients, the first sub-analysis of renal data has also identified a 47 percent drop in decline of kidney function and renal death.

READ MORE ›
alt_text

Wednesday, Jun 5 2019

What Causes PMS? Hadassah Study Offers Answer, with Implications for Future Research

A new explanation for the mood swings, irritability, and depression, known as Premenstrual syndrome (PMS) has been suggested by a Hadassah Medical Organization study.

READ MORE ›
alt_text

Wednesday, Jun 5 2019

Hadassah Confronts the Comeback of Measles

Measles, a disease we have not seen for a long time, has come back. In the past year and a half, Israel has seen over 4,000 cases, says Prof. Allon Moses, director of the Department of Clinical Microbiology and Infectious Diseases at the Hadassah Medical Organization.

READ MORE ›
alt_text

Wednesday, May 29 2019

First Cath Lab Opens in Northern Neighborhoods of Jerusalem at Hadassah Mount Scopus

Hadassah Hospital Mount Scopus inaugurated the first advanced cardiac catheterization unit serving Jerusalem’s northern neighborhoods.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More